Neoadjuvant Pembrolizumab for Lung Cancer | NEJM
45
0
2023-12-18 17:09
Aspirationally Resectable Neoadjuvant Tx Evolves in NSCLC
(EP.1) 3rd Chest-onco Education 2021 #ChestTU #SPN #NSCLC #lungcancer #chestCT
Iatrogenic Splenic Injury in Colorectal Surgery - Laparoscopic Hemostatic Control
好好的告个别吧~
Laparoscopic Appendectomy Procedure with Dr. George Crawford
肝囊肿手术
Resection of a Mucinous Cystadenoma
USS脊柱通用系统：脊柱侧弯前路矫正术（T12-L5）
0 bullet chats
Please Sign In first
LikesSend-PenFavorites
Scan by WeChatUnauthorized reproduction is prohibited
Adjuvant pembrolizumab can improve disease-free survival among patients
with early-stage non–small-cell lung cancer. The effects of neoadjuvant
pembrolizumab in these patients are unclear.
New research findings are
summarized in this short video.
To see the full article, follow this link: https://nej.md/3WK7LMs
Comments 0
Please to post a comment~
Loading...
Related Suggestion